We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

49 hedge funds and large institutions have $68.5M invested in Marrone Bio Innovations, Inc. in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $69.1M → $68.5M (-$596K)

8% less funds holding

Funds holding: 5349 (-4)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
10
Reduced
16
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
26
State Board of Administration of Florida Retirement System
Florida
$48K
Bank of America
27
Bank of America
North Carolina
$33K +$17.1K +11,046 +105%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$32K
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$30K +$6.8K +4,397 +29%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$30K +$31K +20,071 New
ARTA
31
A.R.T. Advisors
New York
$28K +$29.1K +18,829 New
Citadel Advisors
32
Citadel Advisors
Florida
$27K -$29.3K -18,928 -51%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$22K -$901 -583 -4%
Citigroup
34
Citigroup
New York
$21K -$390 -252 -2%
JP Morgan Chase
35
JP Morgan Chase
New York
$21K +$1.46K +942 +7%
CS
36
Credit Suisse
Switzerland
$17K -$1.34K -864 -7%
AF
37
Allworth Financial
California
$17K
Goldman Sachs
38
Goldman Sachs
New York
$17K +$17.9K +11,573 New
UBS Group
39
UBS Group
Switzerland
$14K -$33.7K -21,780 -70%
Morgan Stanley
40
Morgan Stanley
New York
$12K -$16.4K -10,611 -57%
Legal & General Group
41
Legal & General Group
United Kingdom
$12K
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$9.55K -$8.07K -5,220 -45%
AIP
43
Ameritas Investment Partners
Nebraska
$7K
AG
44
Advisor Group
Arizona
$6K
CFA
45
Carroll Financial Associates
North Carolina
$3K
GRP
46
Global Retirement Partners
California
$2K +$1.55K +1,000 New
GI
47
Gradient Investments
Minnesota
$1K
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$1K
FDCDDQ
49
Federation des caisses Desjardins du Quebec
Quebec, Canada
$750
ECM
50
ExodusPoint Capital Management
New York
-$49K -32,300 Closed

MBII Hedge Fund Activity: Q2 2019 in Review

49 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2019, worth a combined $68.5M — down 0.86% from $69.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MBII and 7 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $868K. The largest seller was Primecap Management, cutting an estimated $215K.

  • 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2019, down from 53 in Q1 2019.
  • Funds reported $68.5M of Marrone Bio Innovations, Inc. stock for Q2 2019, down 0.86% quarter-over-quarter.
  • 7 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2019 and 9 closed out, a net change of -2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2019 was Essex Investment Management, an estimated $868K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2019 was Primecap Management, an estimated $215K sold.

Based on aggregated 13F filings for Q2 2019.